National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia; Behaviours and Health Risks, Burnet Institute, Melbourne, Australia; National Drug Research Institute, Curtin University, Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University, Australia.
Drug Alcohol Depend. 2021 Sep 1;226:108882. doi: 10.1016/j.drugalcdep.2021.108882. Epub 2021 Jun 25.
Comorbid chronic health conditions place people who inject drugs (PWID) at risk of severe health outcomes after influenza infection. However, little is known about the uptake, barriers and correlates of influenza vaccination among PWID.
During structured surveys, 872 PWID reported whether they had received an influenza vaccination during the last year (disaggregated as pre- or post-March 2020 to ascertain current season vaccine uptake), and if not, the barriers to vaccination. Logistic regression was used to examine demographic, drug use, health and service engagement correlates of vaccine uptake.
Thirty-nine percent of participants reported past-year influenza vaccination, with one-quarter (24 %) vaccinated in the current season. The main barriers to vaccination were motivation-based, with few citing issues relating to affordability, supply or perceived stigma. Opioid agonist therapy in the past six months was significantly associated with vaccination.
Influenza vaccine uptake was lower among PWID than the Australian general population. Provision of the vaccine at services commonly accessed by PWID may increase uptake.
合并慢性健康状况使吸毒者（PWID）在感染流感后面临严重健康后果的风险。然而，人们对 PWID 接种流感疫苗的情况、障碍和相关因素知之甚少。
在结构化调查中，872 名吸毒者报告了他们在过去一年中是否接种过流感疫苗（分为 2020 年 3 月之前或之后，以确定当前季节的疫苗接种率），如果没有，他们接种疫苗的障碍是什么。使用逻辑回归来检查与疫苗接种率相关的人口统计学、药物使用、健康和服务参与因素。
39%的参与者报告了过去一年的流感疫苗接种情况，其中四分之一（24%）在当前季节接种了疫苗。接种疫苗的主要障碍是基于动机的，很少有人提到与负担能力、供应或感知耻辱有关的问题。过去六个月内使用阿片类激动剂治疗与接种疫苗显著相关。
吸毒者的流感疫苗接种率低于澳大利亚普通人群。在 PWID 常去的服务场所提供疫苗可能会增加接种率。
